Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027
Cold Chain Products Market for Plasma Fractionation by Type (Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator), End User - Global Forecast to 2027
Abstract
The global market for cold chain products in plasma fractionation is estimated to grow significantly. By 2027, it is projected to reach a value of USD 711 million, showing a compound annual growth rate (CAGR) of 4.5% during the forecast period, starting from USD 569 million in 2022.
The expansion of the cold chain products market is driven by various factors, including increasing concerns regarding zoonotic diseases, growing utilization of immunoglobulins and other plasma products in diverse therapeutic areas, and a rising demand for plasma-derived medicinal products. The industry for cold chain products is expected to progress due to the increasing need for plasma freezers and other cold chain products, as well as the adoption of advanced cold storage devices. These advancements in technology contribute to the overall growth and development of the cold chain products sector.
“Ultra-low temperature freezer segment was dominated by the highest share in Cold Chain Products Market for Plasma Fractionation”
The market for Cold Chain Products for Plasma Fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others.
The Ultra-low temperature freezer segment accounted for the highest share of the global Cold Chain Products for Plasma Fractionation in 2021. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period.
"Blood collection centers and blood component providers accounted for the fastest growing segment of the Cold Chain Products Market for Plasma Fractionation in 2021."
The Cold Chain Products Market for Plasma Fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, Blood collection centers and blood component providers held the highest market share for cold chain products for plasma fractionation. Growing demand for plasma fractionation, rising awareness and screening for blood-borne diseases, and expansion of healthcare infrastructure are some of the factors that contribute to the big proportion of this market.
"Latin America is expected to witness the fastest growth in the forecast period." In the forecast period, Latin America in the Cold Chain Products Market for Plasma Fractionation will have the fastest rising regional growth. Large number of hospitals and healthcare facilities, increasing spread of chronic diseases such as immune deficiencies, hemophilia, and autoimmune disorders are the main factors driving market growth.
The rise of these illnesses in Latin America has resulted in a higher requirement for plasma freezers and refrigerators to preserve vital medical resources. In response to growing healthcare needs, advancements in medical treatments, and a growing understanding of the advantages of plasma-based products, the plasma fractionation sector in Latin America has been expanding. This expansion drives the need for suitable storage devices, such as plasma freezers and refrigerators.
Following is a list of the major players (supply-side) in the Cold Chain Products Market for Plasma Fractionation that this study refers to: By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20% By Designation: C-level- 35%, Director Level—25%, and Others- 40% By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2% Several of the major companies in the market for Cold Chain Products for Plasma Fractionation include B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
Research Coverage:
The market study analyzes the main market segments for cold chain products. The objective of this study is to estimate the market's size and growth potential across several categories according to type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.
Key Benefits of Buying the Report:
The study provides data regarding the cold chain products market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.
The report provides insights on the following pointers:
Analysis of key drivers (Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems), opportunities (Demand for Plasma Fractionation Centre and Government support for cold chain infrastructure development), and challenges (Shortage of trained manpower & limited resources to maintain the equipment, Stringent government regulations, and Environmental concerns regarding greenhouse gas emissions) influencing the growth of the Cold Chain Products Market for Plasma Fractionation.
Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for Cold Chain Products Market for Plasma Fractionation
Market Development:
Comprehensive data on attractive markets, and the research analyzes the global Cold Chain Products Market for Plasma Fractionation
Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the Cold Chain Products Market for Plasma Fractionation.
Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the Cold Chain Products Market for Plasma Fractionation like B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
Content
Table of Contents
1INTRODUCTION22
1.1STUDY OBJECTIVES22
1.2MARKET DEFINITION22
1.2.1INCLUSIONS AND EXCLUSIONS22
1.3MARKET SCOPE23
FIGURE 1COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION23
FIGURE 2COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION23
1.3.1YEARS CONSIDERED24
1.4CURRENCY CONSIDERED24
1.5STAKEHOLDERS25
2RESEARCH METHODOLOGY26
2.1RESEARCH APPROACH26
FIGURE 3RESEARCH DESIGN26
2.1.1SECONDARY DATA27
2.1.1.1Key data from secondary sources27
2.1.2PRIMARY DATA28
FIGURE 4PRIMARY SOURCES28
2.1.2.1Key data from primary sources29
2.1.2.2Key industry insights30
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION30
2.2MARKET SIZE ESTIMATION31
FIGURE 6MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS31
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US)32
FIGURE 8SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021)32
FIGURE 9COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH33
FIGURE 10DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR34
FIGURE 11CAGR PROJECTIONS34
FIGURE 12TOP-DOWN APPROACH35
2.3LIMITATIONS35
2.3.1METHODOLOGY-RELATED LIMITATIONS36
2.3.2MARKET BREAKDOWN & DATA TRIANGULATION36
FIGURE 13MARKET DATA TRIANGULATION METHODOLOGY36
2.4MARKET SHARE ANALYSIS37
2.5STUDY ASSUMPTIONS37
2.6RISK ASSESSMENT38
2.7RECESSION IMPACT ANALYSIS38
3EXECUTIVE SUMMARY39
FIGURE 14COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION)39
FIGURE 15COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION)40
FIGURE 16COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT41
4PREMIUM INSIGHTS42
4.1COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW42
FIGURE 17RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH42
4.2ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021)43
FIGURE 18ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE43
4.3COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES44
FIGURE 19CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD44
4.4COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX44
FIGURE 20NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD44
4.5COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES45
FIGURE 21DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD45
5MARKET OVERVIEW46
5.1INTRODUCTION46
5.2MARKET DYNAMICS46
FIGURE 22COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES46
5.2.1DRIVERS46
5.2.1.1Rising use of immunoglobulins and other plasma products46
FIGURE 23WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 202647
5.2.1.2Increasing demand for plasma-derived medicinal products to treat chronic diseases47
TABLE 1PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS48
5.2.1.3Technological advancements in refrigeration equipment and systems48
5.2.2OPPORTUNITIES49
5.2.2.1Demand for plasma fractionation centers49
FIGURE 24PLASMA FRACTIONATION PLANTS WORLDWIDE (2018)49
5.2.2.2Government support for cold chain infrastructure development50
5.2.3CHALLENGES50
5.2.3.1Shortage of trained manpower and limited resources to maintain equipment50
5.2.3.2Stringent government regulations50
5.2.3.3Environmental concerns regarding greenhouse gas emissions51
5.3PRICING ANALYSIS51
5.3.1AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE51
TABLE 2AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD)51
5.3.2AVERAGE SELLING PRICE TRENDS52
5.4SUPPLY CHAIN ANALYSIS52
FIGURE 25SUPPLY CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION52
5.5ECOSYSTEM ANALYSIS53
FIGURE 26ECOSYSTEM ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION54
5.6PATENT ANALYSIS54
FIGURE 27PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023)54
FIGURE 28TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023)55
5.7VALUE CHAIN ANALYSIS55
FIGURE 29VALUE CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION56
5.8TECHNOLOGY ANALYSIS56
5.8.1KEY TECHNOLOGY56
5.8.1.1Ultra-low freezer technology56
5.8.2ADJACENT TECHNOLOGY57
5.8.2.1Cryopreservation57
5.9REGULATORY LANDSCAPE57
5.9.1REGULATORY ANALYSIS57
5.9.1.1North America57
5.9.1.2Europe58
5.9.1.3Asia Pacific58
5.9.1.4Latin America59
5.9.1.5Middle East and Africa59
5.9.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION60
TABLE 3NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS60
TABLE 4EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 5ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS62
5.10PORTER’S FIVE FORCES ANALYSIS62
TABLE 6PORTER’S FIVE FORCES ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION62
5.10.1INTENSITY OF COMPETITIVE RIVALRY63
5.10.2BARGAINING POWER OF SUPPLIERS63
5.10.3BARGAINING POWER OF BUYERS63
5.10.4THREAT OF NEW ENTRANTS63
5.10.5THREAT OF SUBSTITUTES64
5.11KEY CONFERENCES AND EVENTS, 2023–202464
TABLE 7COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–202464
5.12KEY STAKEHOLDERS AND BUYING CRITERIA65
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS65
FIGURE 30INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION65
TABLE 8INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION65
5.12.2BUYING CRITERIA66
TABLE 9KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION66
5.13TRADE ANALYSIS67
TABLE 10EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)67
TABLE 11IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)68
5.14COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT69
6COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE70
6.1INTRODUCTION71
TABLE 12COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)71
TABLE 13COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)72
6.2ULTRA-LOW-TEMPERATURE FREEZERS72
6.2.1RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH72
TABLE 14ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)73
6.3PLASMA FREEZERS74
6.3.1RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH74
TABLE 15PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)74
6.4TEMPERATURE MONITORING DEVICES75
6.4.1ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET75
TABLE 16TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)76
6.5PLASMA CONTACT SHOCK FREEZERS76
6.5.1NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET76
TABLE 17PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)77
6.6BLOOD TRANSPORT BOXES77
6.6.1RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET77
TABLE 18BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)78
6.7ICE-LINED REFRIGERATORS78
6.7.1COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION78
TABLE 19ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)79
6.8OTHER PRODUCTS79
TABLE 20OTHER COLD CHAIN PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)80
7COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER81
7.1INTRODUCTION82
TABLE 21COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)82
7.2BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS82
7.2.1RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH82
TABLE 22COLD CHAIN PRODUCTS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)83
7.3HOSPITALS & TRANSFUSION CENTERS83
7.3.1NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH83
TABLE 23COLD CHAIN PRODUCTS MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)84
7.4CLINICAL RESEARCH LABORATORIES84
7.4.1ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH84
TABLE 24COLD CHAIN PRODUCTS MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)85
7.5OTHER END USERS85
TABLE 25COLD CHAIN PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)86
8COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION87
8.1INTRODUCTION88
FIGURE 31COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES88
TABLE 26COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION)89
8.2NORTH AMERICA89
8.2.1NORTH AMERICA: RECESSION IMPACT89
FIGURE 32NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT90
TABLE 27NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)90
TABLE 28NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)91
TABLE 29NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)91
8.2.2US92
8.2.2.1US to hold largest share of North American market92
TABLE 30US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)92
TABLE 31US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)93
8.2.3CANADA93
8.2.3.1Growing pharma R&D and increasing use of plasma-derived compounds to boost market93
TABLE 32CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)94
TABLE 33CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)94
8.3EUROPE95
8.3.1EUROPE: RECESSION IMPACT95
TABLE 34EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)95
TABLE 35EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)96
TABLE 36EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)96
8.3.2GERMANY97
8.3.2.1Germany to dominate European market97
TABLE 37GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)97
TABLE 38GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)98
8.3.3FRANCE98
8.3.3.1Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market98
TABLE 39FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)99
TABLE 40FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)99
8.3.4UK100
8.3.4.1Rising incidence of hemophilia and growing consumption of coagulation factors to propel market100
TABLE 41UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)100
TABLE 42UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)101
8.3.5ITALY101
8.3.5.1Strong pharma sector and rising geriatric population to support market101
TABLE 43ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)102
TABLE 44ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)102
8.3.6SPAIN103
8.3.6.1Rising chronic disease prevalence to boost demand103
TABLE 45SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 46SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)104
8.3.7REST OF EUROPE104
TABLE 47REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 48REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)105
8.4ASIA PACIFIC106
8.4.1ASIA PACIFIC: RECESSION IMPACT106
FIGURE 33APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT107
TABLE 49ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 50ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 51ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)109
8.4.2CHINA109
8.4.2.1China to dominate Asia Pacific market109
TABLE 52CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 53CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)110
8.4.3JAPAN111
8.4.3.1Growing aging population and rising prevalence of neurological disorders to propel growth111
TABLE 54JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 55JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)112
8.4.4INDIA112
8.4.4.1Growing pharma-biotech industry to drive demand112
TABLE 56INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 57INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)113
8.4.5SOUTH KOREA114
8.4.5.1Rising awareness, advancements in medical treatments, and aging population to drive market114
TABLE 58SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)114
TABLE 59SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)115
8.4.6AUSTRALIA115
8.4.6.1Rising demand for plasma products to treat chronic diseases to propel market115
TABLE 60AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 61AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)116
8.4.7REST OF ASIA PACIFIC117
TABLE 62REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)117
TABLE 63REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)118
8.5LATIN AMERICA118
8.5.1RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET118
8.5.2LATIN AMERICA: RECESSION IMPACT118
TABLE 64LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 65LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)119
8.6MIDDLE EAST & AFRICA120
8.6.1INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES120
8.6.2MIDDLE EAST & AFRICA: RECESSION IMPACT120
TABLE 66MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 67MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)121
9COMPETITIVE LANDSCAPE122
9.1OVERVIEW122
9.2KEY PLAYER STRATEGIES122
TABLE 68OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION123
9.3REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION124
FIGURE 34REVENUE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION MARKET124
9.4MARKET SHARE ANALYSIS125
FIGURE 35COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021125
TABLE 69COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION126
FIGURE 36R&D ASSESSMENT OF KEY PLAYERS127
9.5COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021127
9.5.1STARS127
9.5.2PERVASIVE PLAYERS127
9.5.3EMERGING LEADERS127
9.5.4PARTICIPANTS128
FIGURE 37COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021128
9.6COMPETITIVE BENCHMARKING129
TABLE 70OVERALL COMPANY FOOTPRINT129
TABLE 71COMPANY FOOTPRINT ANALYSIS, BY TYPE130
TABLE 72COMPANY FOOTPRINT ANALYSIS, BY END USER131
TABLE 73COMPANY FOOTPRINT ANALYSIS, BY REGION132
9.7COMPETITIVE SCENARIO133
9.7.1PRODUCT LAUNCHES & APPROVALS133
TABLE 74PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023133
9.7.2DEALS134
TABLE 75DEALS, JANUARY 2021–MARCH 2023134
9.7.3OTHER DEVELOPMENTS134
TABLE 76OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023134
10COMPANY PROFILES135
(Business overview, Products offered, Recent Developments, MNM view)*
10.1KEY PLAYERS135
10.1.1THERMO FISHER SCIENTIFIC, INC.135
TABLE 77THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW135
FIGURE 38THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT136
10.1.2HAIER BIOMEDICAL (HAIER GROUP)139
TABLE 78HAIER BIOMEDICAL: BUSINESS OVERVIEW139
FIGURE 39HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021)140
10.1.3EPPENDORF SE143
TABLE 79EPPENDORF AG: BUSINESS OVERVIEW143
FIGURE 40EPPENDORF AG: COMPANY SNAPSHOT144
10.1.4B MEDICAL SYSTEMS (AZENTA)147
TABLE 80B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW147
FIGURE 41B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021)148
10.1.5BLUE STAR LIMITED150
TABLE 81BLUE STAR LIMITED: BUSINESS OVERVIEW150
FIGURE 42BLUE STAR LIMITED: COMPANY SNAPSHOT151
TABLE 82BLUE STAR LIMITED: PRODUCTS OFFERED151
10.1.6AVANTOR, INC.153
TABLE 83AVANTOR, INC.: BUSINESS OVERVIEW153
FIGURE 43AVANTOR, INC.: COMPANY SNAPSHOT154
10.1.7GODREJ AND BOYCE MANUFACTURING CO. LTD.156
TABLE 84GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW156
FIGURE 44GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT156
10.1.8BIOLIFE SOLUTIONS158
TABLE 85BIOLIFE SOLUTIONS: BUSINESS OVERVIEW158
FIGURE 45BIOLIFE SOLUTIONS: COMPANY SNAPSHOT159
10.1.9HELMER SCIENTIFIC161
TABLE 86HELMER SCIENTIFIC: BUSINESS OVERVIEW161
10.1.10VESTFROST SOLUTIONS A/S164
TABLE 87VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW164
10.1.11JEIO TECH INC.165
TABLE 88JEIO TECH INC.: BUSINESS OVERVIEW165
10.1.12DEEPEE COOLING PRODUCTS166
TABLE 89DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW166
10.1.13BERLINGER & CO. AG167
TABLE 90BERLINGER & CO. AG: BUSINESS OVERVIEW167
10.1.14MONNIT CORPORATION169
TABLE 91MONNIT CORPORATION: BUSINESS OVERVIEW169
10.1.15ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.171
TABLE 92ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW171
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2OTHER PLAYERS173
10.2.1QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD173
10.2.2EBAC CO., LTD.174
10.2.3BIOTECNO175
10.2.4ZHONGKE MEILING CRYOGENICS CO., LTD.176
10.2.5BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.177
10.2.6STERICOX INDIA PRIVATE LIMITED178
10.2.7ENVIRO TECHNOLOGIES179
10.2.8WITHNELL SENSORS179
10.2.9TECNOSOFT SRL180
10.2.10PHILIPP KIRSCH GMBH181
11APPENDIX183
11.1DISCUSSION GUIDE183
11.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL187
11.3RELATED REPORTS189
11.4AUTHOR DETAILS190
The expansion of the cold chain products market is driven by various factors, including increasing concerns regarding zoonotic diseases, growing utilization of immunoglobulins and other plasma products in diverse therapeutic areas, and a rising demand for plasma-derived medicinal products. The industry for cold chain products is expected to progress due to the increasing need for plasma freezers and other cold chain products, as well as the adoption of advanced cold storage devices. These advancements in technology contribute to the overall growth and development of the cold chain products sector.
“Ultra-low temperature freezer segment was dominated by the highest share in Cold Chain Products Market for Plasma Fractionation”
The market for Cold Chain Products for Plasma Fractionation is divided into seven types such as Ultra-low temperature freezer, Plasma freezer, Temperature monitoring devices, Plasma contact shock freezer, Blood transport boxes, Ice-lined refrigerator, and Others.
The Ultra-low temperature freezer segment accounted for the highest share of the global Cold Chain Products for Plasma Fractionation in 2021. Increasing Demand for Plasma-Derived Medicinal Products, Advancements in Plasma Fractionation Technologies, and Growing Need for Cold Chain Infrastructure all some of the factors that are anticipated to promote market expansion throughout the projected period.
"Blood collection centers and blood component providers accounted for the fastest growing segment of the Cold Chain Products Market for Plasma Fractionation in 2021."
The Cold Chain Products Market for Plasma Fractionation is divided into Blood collection centers and blood component providers, Hospitals and transfusion centers, Clinical research laboratories, and Others based on end users. In 2021, Blood collection centers and blood component providers held the highest market share for cold chain products for plasma fractionation. Growing demand for plasma fractionation, rising awareness and screening for blood-borne diseases, and expansion of healthcare infrastructure are some of the factors that contribute to the big proportion of this market.
"Latin America is expected to witness the fastest growth in the forecast period." In the forecast period, Latin America in the Cold Chain Products Market for Plasma Fractionation will have the fastest rising regional growth. Large number of hospitals and healthcare facilities, increasing spread of chronic diseases such as immune deficiencies, hemophilia, and autoimmune disorders are the main factors driving market growth.
The rise of these illnesses in Latin America has resulted in a higher requirement for plasma freezers and refrigerators to preserve vital medical resources. In response to growing healthcare needs, advancements in medical treatments, and a growing understanding of the advantages of plasma-based products, the plasma fractionation sector in Latin America has been expanding. This expansion drives the need for suitable storage devices, such as plasma freezers and refrigerators.
Following is a list of the major players (supply-side) in the Cold Chain Products Market for Plasma Fractionation that this study refers to: By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20% By Designation: C-level- 35%, Director Level—25%, and Others- 40% By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle East and Africa-2% Several of the major companies in the market for Cold Chain Products for Plasma Fractionation include B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
Research Coverage:
The market study analyzes the main market segments for cold chain products. The objective of this study is to estimate the market's size and growth potential across several categories according to type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.
Key Benefits of Buying the Report:
The study provides data regarding the cold chain products market's closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market's pulse and learning about its major drivers, inhibitors, opportunities, and problems.
The report provides insights on the following pointers:
Analysis of key drivers (Rising use of immunoglobulins and other plasma products in a range of therapeutic area, Increasing demand for Plasma-derived medicinal products, and Technological advancements in refrigeration equipment and systems), opportunities (Demand for Plasma Fractionation Centre and Government support for cold chain infrastructure development), and challenges (Shortage of trained manpower & limited resources to maintain the equipment, Stringent government regulations, and Environmental concerns regarding greenhouse gas emissions) influencing the growth of the Cold Chain Products Market for Plasma Fractionation.
Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for Cold Chain Products Market for Plasma Fractionation
Market Development:
Comprehensive data on attractive markets, and the research analyzes the global Cold Chain Products Market for Plasma Fractionation
Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the Cold Chain Products Market for Plasma Fractionation.
Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the Cold Chain Products Market for Plasma Fractionation like B Medical Systems (US), Blue Star Limited (India), Thermo Fisher Scientific (US), Godrej and Boyce Manufacturing Co. Ltd. (India), Haier Biomedical (China), Eppendorf SE (Germany), Avantor, Inc. (US), Biolife Solutions Inc. (US), and Helmer Scientific Inc. (US)
1INTRODUCTION22
1.1STUDY OBJECTIVES22
1.2MARKET DEFINITION22
1.2.1INCLUSIONS AND EXCLUSIONS22
1.3MARKET SCOPE23
FIGURE 1COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SEGMENTATION23
FIGURE 2COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION23
1.3.1YEARS CONSIDERED24
1.4CURRENCY CONSIDERED24
1.5STAKEHOLDERS25
2RESEARCH METHODOLOGY26
2.1RESEARCH APPROACH26
FIGURE 3RESEARCH DESIGN26
2.1.1SECONDARY DATA27
2.1.1.1Key data from secondary sources27
2.1.2PRIMARY DATA28
FIGURE 4PRIMARY SOURCES28
2.1.2.1Key data from primary sources29
2.1.2.2Key industry insights30
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION30
2.2MARKET SIZE ESTIMATION31
FIGURE 6MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS31
FIGURE 7REVENUE SHARE ANALYSIS ILLUSTRATION: THERMO FISHER SCIENTIFIC (US)32
FIGURE 8SUPPLY-SIDE ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION (2021)32
FIGURE 9COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: BOTTOM-UP APPROACH33
FIGURE 10DRIVERS, OPPORTUNITIES, AND CHALLENGES (2022–2027): IMPACT ON MARKET GROWTH AND CAGR34
FIGURE 11CAGR PROJECTIONS34
FIGURE 12TOP-DOWN APPROACH35
2.3LIMITATIONS35
2.3.1METHODOLOGY-RELATED LIMITATIONS36
2.3.2MARKET BREAKDOWN & DATA TRIANGULATION36
FIGURE 13MARKET DATA TRIANGULATION METHODOLOGY36
2.4MARKET SHARE ANALYSIS37
2.5STUDY ASSUMPTIONS37
2.6RISK ASSESSMENT38
2.7RECESSION IMPACT ANALYSIS38
3EXECUTIVE SUMMARY39
FIGURE 14COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2022 VS. 2027 (USD MILLION)39
FIGURE 15COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2022 VS. 2027 (USD MILLION)40
FIGURE 16COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC SNAPSHOT41
4PREMIUM INSIGHTS42
4.1COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET OVERVIEW42
FIGURE 17RISING USE OF IMMUNOGLOBULINS AND OTHER PLASMA PRODUCTS TO DRIVE MARKET GROWTH42
4.2ASIA PACIFIC: COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION, BY TYPE & COUNTRY (2021)43
FIGURE 18ULTRA-LOW-TEMPERATURE FREEZERS TO HOLD LARGEST MARKET SHARE43
4.3COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES44
FIGURE 19CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD44
4.4COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: GEOGRAPHIC MIX44
FIGURE 20NORTH AMERICA TO DOMINATE MARKET OVER FORECAST PERIOD44
4.5COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: DEVELOPING VS. DEVELOPED COUNTRIES45
FIGURE 21DEVELOPING COUNTRIES TO PRESENT GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING THE FORECAST PERIOD45
5MARKET OVERVIEW46
5.1INTRODUCTION46
5.2MARKET DYNAMICS46
FIGURE 22COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES46
5.2.1DRIVERS46
5.2.1.1Rising use of immunoglobulins and other plasma products46
FIGURE 23WORLDWIDE POLYVALENT IMMUNE GLOBULIN SALES FROM 2010 TO 202647
5.2.1.2Increasing demand for plasma-derived medicinal products to treat chronic diseases47
TABLE 1PLASMA-DERIVED MEDICINAL PRODUCTS AND THEIR CLINICAL INDICATIONS48
5.2.1.3Technological advancements in refrigeration equipment and systems48
5.2.2OPPORTUNITIES49
5.2.2.1Demand for plasma fractionation centers49
FIGURE 24PLASMA FRACTIONATION PLANTS WORLDWIDE (2018)49
5.2.2.2Government support for cold chain infrastructure development50
5.2.3CHALLENGES50
5.2.3.1Shortage of trained manpower and limited resources to maintain equipment50
5.2.3.2Stringent government regulations50
5.2.3.3Environmental concerns regarding greenhouse gas emissions51
5.3PRICING ANALYSIS51
5.3.1AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE51
TABLE 2AVERAGE SELLING PRICE OF COLD CHAIN PRODUCTS, BY TYPE (USD)51
5.3.2AVERAGE SELLING PRICE TRENDS52
5.4SUPPLY CHAIN ANALYSIS52
FIGURE 25SUPPLY CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION52
5.5ECOSYSTEM ANALYSIS53
FIGURE 26ECOSYSTEM ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION54
5.6PATENT ANALYSIS54
FIGURE 27PATENT PUBLICATION TRENDS (JANUARY 2013–MARCH 2023)54
FIGURE 28TOP APPLICANTS (COMPANIES/INSTITUTES) FOR COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION PATENTS (2013–2023)55
5.7VALUE CHAIN ANALYSIS55
FIGURE 29VALUE CHAIN ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION56
5.8TECHNOLOGY ANALYSIS56
5.8.1KEY TECHNOLOGY56
5.8.1.1Ultra-low freezer technology56
5.8.2ADJACENT TECHNOLOGY57
5.8.2.1Cryopreservation57
5.9REGULATORY LANDSCAPE57
5.9.1REGULATORY ANALYSIS57
5.9.1.1North America57
5.9.1.2Europe58
5.9.1.3Asia Pacific58
5.9.1.4Latin America59
5.9.1.5Middle East and Africa59
5.9.2REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATION60
TABLE 3NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS60
TABLE 4EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS61
TABLE 5ASIA PACIFIC AND ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS62
5.10PORTER’S FIVE FORCES ANALYSIS62
TABLE 6PORTER’S FIVE FORCES ANALYSIS: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION62
5.10.1INTENSITY OF COMPETITIVE RIVALRY63
5.10.2BARGAINING POWER OF SUPPLIERS63
5.10.3BARGAINING POWER OF BUYERS63
5.10.4THREAT OF NEW ENTRANTS63
5.10.5THREAT OF SUBSTITUTES64
5.11KEY CONFERENCES AND EVENTS, 2023–202464
TABLE 7COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: KEY CONFERENCES AND EVENTS, 2023–202464
5.12KEY STAKEHOLDERS AND BUYING CRITERIA65
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS65
FIGURE 30INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION65
TABLE 8INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION65
5.12.2BUYING CRITERIA66
TABLE 9KEY BUYING CRITERIA FOR TOP THREE TYPES OF COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION66
5.13TRADE ANALYSIS67
TABLE 10EXPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)67
TABLE 11IMPORTS OF COLD CHAIN STORAGE LABORATORY EQUIPMENT (2022)68
5.14COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: RECESSION IMPACT69
6COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE70
6.1INTRODUCTION71
TABLE 12COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)71
TABLE 13COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)72
6.2ULTRA-LOW-TEMPERATURE FREEZERS72
6.2.1RISING DEMAND IN PLASMA STORAGE APPLICATIONS TO DRIVE MARKET GROWTH72
TABLE 14ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)73
6.3PLASMA FREEZERS74
6.3.1RISING DEMAND IN SCIENTIFIC AND THERAPEUTIC APPLICATIONS TO BOOST GROWTH74
TABLE 15PLASMA FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)74
6.4TEMPERATURE MONITORING DEVICES75
6.4.1ADOPTION OF NOVEL TECHNOLOGIES IN TEMPERATURE MONITORING DEVICES TO PROPEL MARKET75
TABLE 16TEMPERATURE MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)76
6.5PLASMA CONTACT SHOCK FREEZERS76
6.5.1NEED FOR RAPID FREEZING IN PLASMA TRANSPORT TO DRIVE MARKET76
TABLE 17PLASMA CONTACT SHOCK FREEZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)77
6.6BLOOD TRANSPORT BOXES77
6.6.1RISING ADOPTION OF TEMPERATURE-CONTROLLED BOXES TO TRANSPORT PLASMA FRACTIONATED COMPOUNDS TO DRIVE MARKET77
TABLE 18BLOOD TRANSPORT BOXES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)78
6.7ICE-LINED REFRIGERATORS78
6.7.1COST-EFFECTIVENESS TO PROPEL END-USER ADOPTION78
TABLE 19ICE-LINED REFRIGERATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)79
6.8OTHER PRODUCTS79
TABLE 20OTHER COLD CHAIN PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)80
7COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER81
7.1INTRODUCTION82
TABLE 21COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)82
7.2BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS82
7.2.1RISING DEMAND FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH82
TABLE 22COLD CHAIN PRODUCTS MARKET FOR BLOOD COLLECTION CENTERS & BLOOD COMPONENT PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)83
7.3HOSPITALS & TRANSFUSION CENTERS83
7.3.1NEED TO ENSURE SAFE COLLECTION, STORAGE, AND COLD CHAIN MANAGEMENT OF PLASMA TO DRIVE MARKET GROWTH83
TABLE 23COLD CHAIN PRODUCTS MARKET FOR HOSPITALS & TRANSFUSION CENTERS, BY COUNTRY, 2020–2027 (USD MILLION)84
7.4CLINICAL RESEARCH LABORATORIES84
7.4.1ROLE OF LABS IN PLASMA FRACTIONATION AND COLD CHAIN PRODUCT DEVELOPMENT TO BOOST MARKET GROWTH84
TABLE 24COLD CHAIN PRODUCTS MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)85
7.5OTHER END USERS85
TABLE 25COLD CHAIN PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)86
8COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION87
8.1INTRODUCTION88
FIGURE 31COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: GEOGRAPHIC GROWTH OPPORTUNITIES88
TABLE 26COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY REGION, 2020–2027 (USD MILLION)89
8.2NORTH AMERICA89
8.2.1NORTH AMERICA: RECESSION IMPACT89
FIGURE 32NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT90
TABLE 27NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)90
TABLE 28NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)91
TABLE 29NORTH AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)91
8.2.2US92
8.2.2.1US to hold largest share of North American market92
TABLE 30US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)92
TABLE 31US: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)93
8.2.3CANADA93
8.2.3.1Growing pharma R&D and increasing use of plasma-derived compounds to boost market93
TABLE 32CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)94
TABLE 33CANADA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)94
8.3EUROPE95
8.3.1EUROPE: RECESSION IMPACT95
TABLE 34EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)95
TABLE 35EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)96
TABLE 36EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)96
8.3.2GERMANY97
8.3.2.1Germany to dominate European market97
TABLE 37GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)97
TABLE 38GERMANY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)98
8.3.3FRANCE98
8.3.3.1Growing biotech & pharma industry and high prevalence of bleeding disorders to drive market98
TABLE 39FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)99
TABLE 40FRANCE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)99
8.3.4UK100
8.3.4.1Rising incidence of hemophilia and growing consumption of coagulation factors to propel market100
TABLE 41UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)100
TABLE 42UK: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)101
8.3.5ITALY101
8.3.5.1Strong pharma sector and rising geriatric population to support market101
TABLE 43ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)102
TABLE 44ITALY: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)102
8.3.6SPAIN103
8.3.6.1Rising chronic disease prevalence to boost demand103
TABLE 45SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 46SPAIN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)104
8.3.7REST OF EUROPE104
TABLE 47REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 48REST OF EUROPE: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)105
8.4ASIA PACIFIC106
8.4.1ASIA PACIFIC: RECESSION IMPACT106
FIGURE 33APAC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION SNAPSHOT107
TABLE 49ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY COUNTRY, 2020–2027 (USD MILLION)108
TABLE 50ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 51ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)109
8.4.2CHINA109
8.4.2.1China to dominate Asia Pacific market109
TABLE 52CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)110
TABLE 53CHINA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)110
8.4.3JAPAN111
8.4.3.1Growing aging population and rising prevalence of neurological disorders to propel growth111
TABLE 54JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 55JAPAN: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)112
8.4.4INDIA112
8.4.4.1Growing pharma-biotech industry to drive demand112
TABLE 56INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 57INDIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)113
8.4.5SOUTH KOREA114
8.4.5.1Rising awareness, advancements in medical treatments, and aging population to drive market114
TABLE 58SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)114
TABLE 59SOUTH KOREA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)115
8.4.6AUSTRALIA115
8.4.6.1Rising demand for plasma products to treat chronic diseases to propel market115
TABLE 60AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 61AUSTRALIA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)116
8.4.7REST OF ASIA PACIFIC117
TABLE 62REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)117
TABLE 63REST OF ASIA PACIFIC: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)118
8.5LATIN AMERICA118
8.5.1RISING INVESTMENTS IN BRAZIL AND GROWING DISEASE PREVALENCE ACROSS LATAM TO BOOST MARKET118
8.5.2LATIN AMERICA: RECESSION IMPACT118
TABLE 64LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 65LATIN AMERICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)119
8.6MIDDLE EAST & AFRICA120
8.6.1INFRASTRUCTURAL DEVELOPMENT IN HEALTHCARE TO OFFER GROWTH OPPORTUNITIES120
8.6.2MIDDLE EAST & AFRICA: RECESSION IMPACT120
TABLE 66MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 67MIDDLE EAST & AFRICA: COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION, BY END USER, 2020–2027 (USD MILLION)121
9COMPETITIVE LANDSCAPE122
9.1OVERVIEW122
9.2KEY PLAYER STRATEGIES122
TABLE 68OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION123
9.3REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION124
FIGURE 34REVENUE ANALYSIS FOR KEY PLAYERS IN COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION MARKET124
9.4MARKET SHARE ANALYSIS125
FIGURE 35COLD CHAIN PRODUCTS FOR PLASMA FRACTIONATION: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021125
TABLE 69COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: DEGREE OF COMPETITION126
FIGURE 36R&D ASSESSMENT OF KEY PLAYERS127
9.5COMPANY EVALUATION QUADRANT (KEY COMPANIES), 2021127
9.5.1STARS127
9.5.2PERVASIVE PLAYERS127
9.5.3EMERGING LEADERS127
9.5.4PARTICIPANTS128
FIGURE 37COLD CHAIN PRODUCTS MARKET FOR PLASMA FRACTIONATION: COMPANY EVALUATION MATRIX, 2021128
9.6COMPETITIVE BENCHMARKING129
TABLE 70OVERALL COMPANY FOOTPRINT129
TABLE 71COMPANY FOOTPRINT ANALYSIS, BY TYPE130
TABLE 72COMPANY FOOTPRINT ANALYSIS, BY END USER131
TABLE 73COMPANY FOOTPRINT ANALYSIS, BY REGION132
9.7COMPETITIVE SCENARIO133
9.7.1PRODUCT LAUNCHES & APPROVALS133
TABLE 74PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–MARCH 2023133
9.7.2DEALS134
TABLE 75DEALS, JANUARY 2021–MARCH 2023134
9.7.3OTHER DEVELOPMENTS134
TABLE 76OTHER DEVELOPMENTS, JANUARY 2019– MARCH 2023134
10COMPANY PROFILES135
(Business overview, Products offered, Recent Developments, MNM view)*
10.1KEY PLAYERS135
10.1.1THERMO FISHER SCIENTIFIC, INC.135
TABLE 77THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW135
FIGURE 38THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT136
10.1.2HAIER BIOMEDICAL (HAIER GROUP)139
TABLE 78HAIER BIOMEDICAL: BUSINESS OVERVIEW139
FIGURE 39HAIER BIOMEDICAL (HAIER GROUP): COMPANY SNAPSHOT (2021)140
10.1.3EPPENDORF SE143
TABLE 79EPPENDORF AG: BUSINESS OVERVIEW143
FIGURE 40EPPENDORF AG: COMPANY SNAPSHOT144
10.1.4B MEDICAL SYSTEMS (AZENTA)147
TABLE 80B. MEDICAL SYSTEM (AZENTA): BUSINESS OVERVIEW147
FIGURE 41B MEDICAL SYSTEMS (AZENTA): COMPANY SNAPSHOT (2021)148
10.1.5BLUE STAR LIMITED150
TABLE 81BLUE STAR LIMITED: BUSINESS OVERVIEW150
FIGURE 42BLUE STAR LIMITED: COMPANY SNAPSHOT151
TABLE 82BLUE STAR LIMITED: PRODUCTS OFFERED151
10.1.6AVANTOR, INC.153
TABLE 83AVANTOR, INC.: BUSINESS OVERVIEW153
FIGURE 43AVANTOR, INC.: COMPANY SNAPSHOT154
10.1.7GODREJ AND BOYCE MANUFACTURING CO. LTD.156
TABLE 84GODREJ AND BOYCE MANUFACTURING CO. LTD.: BUSINESS OVERVIEW156
FIGURE 44GODREJ AND BOYCE MANUFACTURING CO. LTD.: COMPANY SNAPSHOT156
10.1.8BIOLIFE SOLUTIONS158
TABLE 85BIOLIFE SOLUTIONS: BUSINESS OVERVIEW158
FIGURE 45BIOLIFE SOLUTIONS: COMPANY SNAPSHOT159
10.1.9HELMER SCIENTIFIC161
TABLE 86HELMER SCIENTIFIC: BUSINESS OVERVIEW161
10.1.10VESTFROST SOLUTIONS A/S164
TABLE 87VESTFROST SOLUTIONS A/S: BUSINESS OVERVIEW164
10.1.11JEIO TECH INC.165
TABLE 88JEIO TECH INC.: BUSINESS OVERVIEW165
10.1.12DEEPEE COOLING PRODUCTS166
TABLE 89DEEPEE COOLING PRODUCTS: BUSINESS OVERVIEW166
10.1.13BERLINGER & CO. AG167
TABLE 90BERLINGER & CO. AG: BUSINESS OVERVIEW167
10.1.14MONNIT CORPORATION169
TABLE 91MONNIT CORPORATION: BUSINESS OVERVIEW169
10.1.15ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.171
TABLE 92ZHEJIANG HELI REFRIGERATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW171
*Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
10.2OTHER PLAYERS173
10.2.1QINGDAO CAREBIOS BIOLOGICAL TECHNOLOGY CO., LTD173
10.2.2EBAC CO., LTD.174
10.2.3BIOTECNO175
10.2.4ZHONGKE MEILING CRYOGENICS CO., LTD.176
10.2.5BIONICS SCIENTIFIC TECHNOLOGIES (P) LTD.177
10.2.6STERICOX INDIA PRIVATE LIMITED178
10.2.7ENVIRO TECHNOLOGIES179
10.2.8WITHNELL SENSORS179
10.2.9TECNOSOFT SRL180
10.2.10PHILIPP KIRSCH GMBH181
11APPENDIX183
11.1DISCUSSION GUIDE183
11.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL187
11.3RELATED REPORTS189
11.4AUTHOR DETAILS190
Related Report
